Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome

NCT01607073 is registered in ClinicalTrials.gov with Gillette Children's Specialty Healthcare as lead sponsor.

NCT NCT01607073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome
Lead sponsor
Gillette Children's Specialty Healthcare
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
January 31, 2015
Enrollment
2 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome